Celmatix Therapeutics

Our CEO and Founder, Dr. Piraye Beim, recently joined Sir Richard Branson, Whole Foods Market founder John Mackey, and a group of other visionary business leaders on Necker Island for the Liberty Ventures Principled Business Summit. The event brought together individuals committed to leveraging their businesses to solve some of the world’s biggest problems. Dr. Beim’s talk highlighted a multi-trillion dollar opportunity hiding in plain sight for many people, which is products designed with women’s unique biological differences in mind. For example, did you know that: ✅ 93% of all food is purchased by women ✅85% of all consumer goods are purchased by women ✅80% of all healthcare decisions are made by women And yet... ✅2/3 of prescription drugs work better for men than for women   ✅1/3 of data gathered across all fields is about women ✅25% more of the female lifespan is spent sick These are just a handful of the countless examples of how women have been significantly underserved. By addressing these gaps, businesses have the opportunity to not only improve women’s health and quality of life but also unlock a multi-trillion dollar market that benefits everyone. It’s time for the world to recognize that designing with women in mind isn’t just the right thing to do, it’s a smart, forward-thinking business move. #womenshealth #healthcare #women #neckerisland #business #returns #investment

As entrepreneurs navigating the startup challenges is a reality that all new founders and CEO face daily. During todays Power of X Summit we asked panelists “When it comes to getting fundraising, what is the one thing you need to always remember when going into investor meetings.” Piraye Beim founder of Celmatix Therapeutics says you must understand your market and what your going to fix and remember you’re always in fundraising mode. Priyanka Jain, Co-founder and CEO of Evvy, who has raised more than $25 million says you must to educate your investors especially in women’s health. #womenshealth

#Endometriosis is often misunderstood, and misinformation is everywhere. This #EndometriosisAwarenessMonth, let’s clear up the myths and spread the facts 🎗️ #EndometriosisAwareness #MythVsFact

What if women's ovaries could stay healthier, longer? Read more on how NY-based Celmatix Therapeutics is developing a first-in-class therapy to extend ovarian function—potentially reducing risks of heart disease, osteoporosis, & cognitive decline. A game-changer for women's health & aging! #womenshealth #therapeutics Piraye Beim

Congratulations to our CEO and Founder Piraye Beim for making the Inc. Magazine Female Founders 2025 list! 🎉

On this International Women’s Day, let’s talk about the health struggles many women face in silence. 1 in 3 women are affected by conditions like endometriosis, premature menopause, and polycystic ovary syndrome (PCOS) all rooted in ovarian dysfunction. These conditions can be debilitating, causing not only physical pain but significant emotional and mental strain. We must continue to raise awareness, provide support, and prioritize women’s health. Every woman deserves to be heard, seen, and empowered. At Celmatix Therapeutics, we believe that female biology is unique, and that women deserve therapeutics made specifically for them so they can live longer, healthier lives. 👏

Honored to be featured in Theresa Neil's latest article in Forbes! "Celmatix Therapeutics is pioneering therapeutics to extend healthy ovarian function and lifespan, addressing fundamental aspects of women's reproductive health." "As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's health biotech is approaching an inflection point similar to what we saw with Genentech and the broader biotech industry. Those early biotech investments led to transformational scientific breakthroughs and created enormous value. Today's investments in women's health innovation appear poised to follow a similar trajectory, not just changing healthcare outcomes, but in reshaping our understanding of what's possible in women's health."

Our CEO and Founder Piraye Beim had the opportunity to present our work at the Endometriosis Foundation of America Medical Conference last week! "We are going to end this disease in our lifetime, for our daughters and for all the other little girls who deserve to thrive in their adolescence. 80% of endometriosis is pediatric onset. We need to stop referring to it as a reproductive condition. It is a chronic, inflammatory pain condition. We need to replace medical gaslighting of girls and their parent advocates with rapid diagnostics and disease modifying treatments. I am proud of our pioneering working at Celmatix Therapeutics to progress a novel JNK inhibitor for endometriosis, with future applications in treating PCOS and ovarian aging." Ft: Sarah Austin Nicole Notar

Interesting research coming out of Rice University! "Led by Anatoly Kolomeisky, professor of chemistry and chemical and biomolecular engineering, the research team has developed a theoretical framework that quantitatively predicts menopause timing. By analyzing how ovarian follicles transition through different stages, the researchers' model explains why menopause occurs, and sheds light on individual variability and cross-population differences. These insights could improve fertility planning, inform health care decisions related to hormonal therapies and enhance our understanding of age-related health risks associated with ovarian aging. "By considering menopause as a sequential process involving random transitions of follicles, we can better understand individual variability and population-wide trends in menopause timing," Kolomeisky said."

Are you heading to SiS: Women's Health NYC event May 15-16? ➡️ https://lnkd.in/ehMQiteZ Don't miss the chance to hear from our CEO & Founder Dr. Piraye Beim!